DFX Intelligence

Venture Capital Intelligence

Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / I••••••••• I•••

I••••••••• I•••

Stage unknownOrlando, FLBiotechnology

Facts

Year of incorporation: unknown
Revenue range (Form D): Decline to Disclosesec.gov
Rounds on record: 7
Disclosed raised: unknownsum of rounds with a disclosed amount only
Named investors: 0

Financing history

7 rounds

May 14, 2026
Form D equity offering · $40,000 (form d sold) · 1 investors
Fact SEC EDGAR Form D data sets (quarterly) · “I••••••••• I••• filed Form D: $40,000 sold (indefinite offering), Biotechnology”
Feb 3, 2024
Form D equity offering · $5.4M (form d sold) · 75 investors
Fact SEC EDGAR Form D data sets (quarterly) · “I••••••••• I••• filed Form D: $5,353,594 sold (indefinite offering), Biotechnology”
Sep 6, 2022
Form D equity offering · $725,274 (form d sold) · 1 investors
Fact SEC EDGAR Form D data sets (quarterly) · “I••••••••• I••• filed Form D: $725,274 sold of $725,274, Biotechnology”
Nov 20, 2021
Form D equity offering · $500,000 (form d sold) · 1 investors
Fact SEC EDGAR Form D data sets (quarterly) · “I••••••••• I••• filed Form D: $500,000 sold (indefinite offering), Biotechnology”
Feb 9, 2021
Form D equity offering · $516,900 (form d sold) · 18 investors
Fact SEC EDGAR Form D data sets (quarterly) · “I••••••••• I••• filed Form D: $516,900 sold (indefinite offering), Biotechnology”
Sep 3, 2020
Form D equity offering · $100,000 (form d sold) · 1 investors
Fact SEC EDGAR Form D data sets (quarterly) · “I••••••••• I••• filed Form D: $100,000 sold (indefinite offering), Biotechnology”
Jul 21, 2018
Form D equity offering · $400,000 (form d sold) · 5 investors
Fact SEC EDGAR Form D data sets (quarterly) · “I••••••••• I••• filed Form D: $400,000 sold (indefinite offering), Biotechnology”

Investors on record

0 edges

No named investor yet.

People

5 officers, 0 directors

C••• A•••• G••••••••• Executive Officer/Director/Promoter sec.gov
S•••• A•••• H••• Executive Officer sec.gov
S•••• A•••• S••••• Executive Officer sec.gov
V•••••• A•••• G••••••••• Executive Officer/Director/Promoter sec.gov
W•••••• S•••• H••• Executive Officer sec.gov

Timeline

May 29, 2026
I••••••••• I••• filed Form D: $40,000 sold (indefinite offering), Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Apr 8, 2026
I••••••••• I••• filed Form D/A: $50,000 sold (indefinite offering), Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Apr 6, 2026
I••••••••• I••• filed Form D: $5,353,594 sold (indefinite offering), Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Apr 6, 2026
I••••••••• I••• filed Form D: $725,274 sold of $725,274, Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Apr 6, 2026
I••••••••• I••• filed Form D: $500,000 sold (indefinite offering), Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Apr 3, 2026
I••••••••• I••• filed Form D: $516,900 sold (indefinite offering), Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Apr 3, 2026
I••••••••• I••• filed Form D: $100,000 sold (indefinite offering), Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Apr 3, 2026
I••••••••• I••• filed Form D: $400,000 sold (indefinite offering), Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)

Evidence

74 observations

Every observation on this company

Entity type: Corporation May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Entity type: Corporation Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Entity type: Corporation Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Entity type: Corporation Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: false May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: true Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: false Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: false Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): Decline to Disclose May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): No Revenues Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): No Revenues Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): No Revenues Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: overFiveYears May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: overFiveYears Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: overFiveYears Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: overFiveYears Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $40,000 May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $50,000 Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $500,000 Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $725,274 Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $5.4M Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $516,900 Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $100,000 Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $400,000 Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Offering amount (Form D): $725,274 Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2026-05-14 May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2021-11-20 Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2021-11-20 Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2024-02-03 Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2022-09-06 Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2018-07-21 Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2021-02-09 Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2020-09-03 Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Indefinite offering: true May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Indefinite offering: true Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Indefinite offering: true Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Indefinite offering: true Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 1 May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 1 Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 75 Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 1 Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 5 Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 1 Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 18 Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 0 May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 0 Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 0 Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 0 Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Offering other type: These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer,typically preferred stock,upon the occurrence of specified triggering events including future financingroundS. May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Offering other type: These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer, typically preferred stock, upon the occurrence of specified triggering events, including future financing rounds. Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Offering other type: These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer, typically preferred stock, upon the occurrence of specified triggering events, including future financing rounds. Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Offering other type: These securities are convertible promissory notes that may convert into equity securities of the issuer, typically preferred stock, upon the occurrence of specified events, including qualified financing. Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Offering other type: These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer, typically preferred stock, upon the occurrence of specified triggering events, including future financing rounds. Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity,option May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity,option Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity,option Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity,option Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Office address: C/O GUIDEWILL INNOVATION CENTER, 6555 SANGER RD. SUITE 100, ORLANDO, FL, 32827 May 29, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Office address: C/O GUIDEWELL INNOVATION CENTER, 6555 SANGER RD, SUITE 100, ORLANDO, FL, 32827 Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Office address: C/O GUIDEWELL INNOVATION CENTER, 6555 SANGER RD, SUITE 100, ORLANDO, FL, 32827 Apr 6, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Office address: C/O GUIDEWELL INNOVATION CENTER, 6555 SANGER RD, SUITE 100, ORLANDO, FL, 32827 Apr 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)